Vranken, L.
Wyers, C. E. http://orcid.org/0000-0001-7662-3990
van Rietbergen, B.
Driessen, J. H. M.
Geusens, P. P. M. M.
Janzing, H. M. J.
van der Velde, R. Y.
van den Bergh, J. P. W.
Funding for this research was provided by:
Stichting De Weijerhorst (na)
Article History
Received: 17 October 2018
Accepted: 3 July 2019
First Online: 17 July 2019
Compliance with ethical standards
: The study protocol (registration number NL45707.072.13) was approved by an independent Medical Ethics Committee and complied with the Declaration of Helsinki. All patients gave written informed consent prior to participation.
: Drs. Vranken has nothing to disclose.Dr. Wyers has nothing to disclose.Dr. van Rietbergen reports personal fees from Scanco Medical AG, outside the submitted work.Dr. Driessen has nothing to disclose.Dr. Geusens reports grants and other from Amgen, grants from Pfizer, grants from MSD, grants from UCB, grants from Abbott, grants and other from Lilly, grants from BMS, grants from Novartis, grants from Roche, and grants from Will Pharma, outside the submitted work.Dr. Janzing has nothing to disclose.Drs. Kaarsemaker has nothing to disclose.Drs. van der Velde has nothing to disclose.Dr. van den Bergh reports grants from Amgen, grants from Will Pharma, and grants from Eli Lilly, outside the submitted work.